Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease. (EIIGETPCHD)

Ministry of Science and Technology of the People´s Republic of China

Status: Unknown

Conditions: Impaired Glucose Tolerance; Coronary Heart Disease

Treatments: Drug: Voglibose tablets

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00724542

2006BAI01A02-11

Details and patient eligibility

About

The purpose of this study is to determine whether therapeutic intervention on impaired glucose tolerance in patients with coronary heart disease can decrease the incidence of new onset DM.

Enrollment: 1,600 estimated patients

Sex: All

Ages: 40 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with coronary heart disease
• Impaired Glucose Tolerance

Exclusion criteria

• Age < 40yr or > 75yr
• Diabetes Mellitus
• Scr > 2.0 mg/dL（176 μmol/L）
• ALT or AST > 2.5 ULN
• Hb < 90g/L
• Heart Failure
• Infection
• Undergo other interventional clinical trial

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

1,600 participants in 2 patient groups

Control

No Intervention group

Description:

Placebo with lifestyle intervention

Drug

Experimental group

Description:

Voglibose tablets with lifestyle intervention

Treatment:

Drug: Voglibose tablets